Cary, NC, United States of America

Alan F Parr

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Glaxo Inc.. Active years: 1992-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan F Parr. Retrieved from https://idiyas.com/inventor/alan-f-parr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 440(Granted Patents)


Company Filing History:


Years Active: 1992-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Alan F Parr: Innovator in Pharmaceutical Technology

Introduction

Alan F Parr is a notable inventor based in Cary, NC (US), recognized for his contributions to pharmaceutical technology. He holds a total of 3 patents, showcasing his innovative approach to drug delivery systems.

Latest Patents

Among his latest inventions is a bi-layer pharmaceutical tablet designed for the immediate and sustained release of ranitidine. This innovative tablet features one layer formulated for immediate release and another for sustained release, with a specific ratio of ranitidine in each layer. Another significant patent is a medical capsule device actuated by a radio-frequency (RF) signal. This device is engineered to release substances at defined locations within the gastrointestinal tract, utilizing a sleeve valve mechanism that operates through a shape memory alloy.

Career Highlights

Alan F Parr is currently associated with Glaxo Inc., where he continues to develop groundbreaking pharmaceutical solutions. His work has significantly impacted the field of medicine, particularly in enhancing drug delivery methods.

Collaborations

He has collaborated with esteemed colleagues such as Robert A Casper and Michael L McCartney, contributing to a dynamic and innovative work environment.

Conclusion

Alan F Parr's inventive spirit and dedication to pharmaceutical advancements have made him a key figure in the industry. His patents reflect a commitment to improving healthcare through innovative drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…